Public Health Agency of Canada

C. trachomatis is the most common reportable sexually transmitted infection in Canada. If not treated, C. trachomatis can spread from a local site of inoculation and lead to serious complications and/or sequelae, such as pelvic inflammatory disease (PID), ectopic pregnancy, infertility, chronic...

Public health involves the organized efforts of society that aim to keep people healthy and to prevent illness, injury and premature death. The Public Health Agency of Canada (PHAC) has put in place programs, services and policies to help protect and promote the health of all Canadians and...

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease...

This Plan outlines the Agency's priorities for the year and it is a guide to help Canadians understand the diverse and strategic ways the Agency strengthens public health at all levels.

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

The first version of the National laboratory testing indication guidance for COVID-19 document was developed at the beginning of the COVID-19 outbreak. The original guidance document was finalized and approved by the Special Advisory Committee on April 16, 2020. Since then, significant...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

This NML Infographic consists of easily measurable work that NML accomplishes annually around Surveillance, Reference Services, Emergency Preparedness, Leadership, Research and Support Managament.

COVID-19 causes a respiratory type infection that is mild in most of the population but can be more severe in those who are older adults or those with chronic underlying conditions. Having a disability alone may not put you at higher risk for getting COVID-19 or having severe illness if you do...

The Public Health Agency of Canada (PHAC), in collaboration with Canadian public health experts has developed this guidance for federal/provincial/territorial (F/P/T) public health authorities (PHA) to support the management of cases and contacts of coronavirus disease 2019 (COVID-19) within...

Together, we can take the following steps to slow the spread of COVID-19.

Take steps to reduce the spread of the coronavirus disease (COVID-19).

Across Canada, we are taking extraordinary steps to prevent the spread of COVID-19. Employers and employees will need to work together to protect the health of employees and clients, and to keep the workplace delivering its essential services.

This guidance updates and consolidates infection prevention and control guidance for managing COVID-19 in acute healthcare settings.

Since the novel coronavirus emerged, the Public Health Agency of Canada and provincial and territorial public health authorities have been working together to ensure a coordinated approach to slow the spread of the virus and to reduce its impacts on our population—especially the most...

Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.

The purpose of this document is to provide guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. The guidance outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2...

This document provides guidance specific to the COVID-19 pandemic for home care providers.

Isolation means staying at home when you have a symptom of COVID-19 and it is possible that you have been exposed to the virus. By avoiding contact with other people, you help prevent the spread of disease to others in your home and your community.

This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.